SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChiRex (CHRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Randy Schmid who wrote (73)9/5/1997 10:26:00 PM
From: Haseltine   of 130
 
A good day indeed! I think I saw that ChiRex has announced that it expects to close on the Glaxo plant acquisition by Sept 30. The CS First Boston analyst has recently set a price target of $28 within the next 12 months. The stock was at $18 then. So maybe that plus the fact that the Glaxo deal is still on track has something to do with the most recent upward trend. But who really knows.

I will be looking very carefully at the next quarterly earnings report. So far ChiRex has always met or beat the analysts' projections and the projections are for 70% per year compounded growth on the bottom line over the next few years. You can't say that about too many companies, especially chemical companies.

Good luck.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News